1. Home
  2. NYAX vs MLYS Comparison

NYAX vs MLYS Comparison

Compare NYAX & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nayax Ltd.

NYAX

Nayax Ltd.

HOLD

Current Price

$65.71

Market Cap

2.5B

Sector

N/A

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$24.23

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NYAX
MLYS
Founded
2005
2019
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.2B
IPO Year
2022
2023

Fundamental Metrics

Financial Performance
Metric
NYAX
MLYS
Price
$65.71
$24.23
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$49.50
$48.67
AVG Volume (30 Days)
28.6K
1.8M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.43
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$30.66
N/A
Revenue Next Year
$21.70
N/A
P/E Ratio
$89.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$39.17
$12.59
52 Week High
$76.86
$47.65

Technical Indicators

Market Signals
Indicator
NYAX
MLYS
Relative Strength Index (RSI) 41.09 38.88
Support Level $63.03 $22.42
Resistance Level $75.85 $31.29
Average True Range (ATR) 1.69 1.66
MACD -1.02 -0.69
Stochastic Oscillator 2.82 20.53

Price Performance

Historical Comparison
NYAX
MLYS

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It unifies payments, operations management, and customer engagement tools into a powerful, adaptable platform for modern commerce. It provides solutions that empower businesses to enhance customer experience, accept cashless payments, and manage their operations with a robust Internet of Things (IoT) software platform, helping achieve long-term growth. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

Share on Social Networks: